October 19, 2026
Business

HAB Pharma targets ₹3,000 crore revenue by 2030 after merger deal(Soban News)

HAB Pharmaceuticals aims to scale operations and expand globally after merging with Signature Phytochemical Industries through a slump sale deal

​HAB Pharmaceuticals aims to scale operations and expand globally after merging with Signature Phytochemical Industries through a slump sale deal by Soban News (international And National News)

Related posts

Stroke patients get younger, scanner on lifestyle, stress – Times of India(Soban News)

News-Soban-Admin

EU opens door for Canada amid trade war with Trump, proposes first-ever associate membership – The Times of India(Soban News)

News-Soban-Admin

Top Philippine Bank Likely to Sustain Record Profit, CEO Says

News-Soban-Admin

Leave a Comment